Reclassification, Thromboembolic, and Major Bleeding Outcomes Using Different Estimates of Renal Function in Anticoagulated Patients With Atrial Fibrillation: Insights From the PREFER-in-AF and PREFER-in-AF Prolongation Registries

Rohla, M., Pecen, L., Cemin, R., Patti, G., Siller-Matula, J. M., Schnabel, R. B., Huber, K., Kirchhof, P., De Caterina, R. Reclassification, Thromboembolic, and Major Bleeding Outcomes Using Different Estimates of Renal Function in Anticoagulated Patients With Atrial Fibrillation: Insights From the PREFER-in-AF and PREFER-in-AF Prolongation Registries. Circulation-Cardiovascular Quality and Outcomes. 2021, 14(6), e006852. ISSN 1941-7705. E-ISSN 1941-7713. Dostupné z: doi: 10.1161/CIRCOUTCOMES.120.006852